Alpha-1-Antitrypsin Deficiency

Search Trials
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Status:
Recruiting
Last Changed:
Apr 19, 2022
First Changed:
Apr 19, 2022
Disease(s):
Chronic Liver Disease
Study of OsrhAAT or Placebo in Healthy Volunteers
Status:
Recruiting
Last Changed:
Apr 14, 2022
First Changed:
Apr 7, 2022
Disease(s):
AATD
Intervention(s):
OsrhAAT 1 mg/kg IVOsrhAAT 3 mg/kg IVOsrhAAT 10 mg/kg IVOsrhAAT 20 mg/kg IVOsrhAAT 40 mg/kg IVOsrhAAT 60 mg/kg IV
A Phase I of OsrhAAT in Healthy Volunteers
Status:
Recruiting
Last Changed:
Apr 7, 2022
First Changed:
Apr 7, 2022
Disease(s):
AATD
Intervention(s):
OsrhAAT 1 mg/kg IVOsrhAAT 3 mg/kg IVOsrhAAT 10 mg/kg IVOsrhAAT 20 mg/kg IVOsrhAAT 40 mg/kg IVOsrhAAT 60 mg/kg IV
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
Status:
Recruiting
Last Changed:
Apr 11, 2022
First Changed:
Mar 28, 2022
Disease(s):
Alpha 1-Antitrypsin Deficiency
Czech AATD Registry
Status:
Recruiting
Last Changed:
Jan 5, 2022
First Changed:
Jan 5, 2022
Disease(s):
Alpha-1-antitrypsin Deficiency

Connect. Empower. Inspire.